Inhibition of diacylglycerol lipase β modulates lipid and endocannabinoid levels in the ex vivo human placenta
IntroductionLipids and fatty acids are key components in metabolic processes of the human placenta, thereby contributing to the development of the fetus. Placental dyslipidemia and aberrant activity of lipases have been linked to diverse pregnancy associated complications, such as preeclampsia and p...
Main Authors: | Natascha Berger, Tom van der Wel, Birgit Hirschmugl, Thomas Baernthaler, Juergen Gindlhuber, Nermeen Fawzy, Thomas Eichmann, Ruth Birner-Gruenberger, Robert Zimmermann, Mario van der Stelt, Christian Wadsack |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1092024/full |
Similar Items
-
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
by: Stefania Petrosino, et al.
Published: (2019-12-01) -
A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase α
by: Tom van der Wel, et al.
Published: (2015-04-01) -
SUCNR1 Is Expressed in Human Placenta and Mediates Angiogenesis: Significance in Gestational Diabetes
by: Reham Atallah, et al.
Published: (2021-11-01) -
Hepatocyte Proteome Alterations Induced by Individual and Combinations of Common Free Fatty Acids
by: Juergen Gindlhuber, et al.
Published: (2022-03-01) -
Proteomic Changes of Activated Hepatic Stellate Cells
by: Maximilian Schinagl, et al.
Published: (2021-11-01)